Calyxt, Inc. announced appointment of Dan Voytas, Ph.D., Calyxt Scientific Advisory Board Chair and Professor in the Department of Genetics, Cell Biology and Development at the University of Minnesota * Anne Osbourn, Ph.D., Group Leader at the John Innes Center * Elizabeth Sattely, Ph.D., HHMI Investigator and Associate Professor of Chemical Engineering, Stanford University * Paul Bernasconi, Ph.D., Former Global Function Head for Molecular Biology at BASF Biosciences to Scientific Advisory Board. Dan Voytas, Ph.D., the inventor of TALEN(R) technology and a co-founder of Calyxt, will immediately assume his new role as Chair of the newly established Scientific Advisory Board.
Cibus, Inc. is an agricultural technology company that uses gene editing technologies to develop plant traits in seeds. Its business is the development of plant traits that help address specific productivity or yield challenges in farming, such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate. It is also engaged in developing, certain alternative plant-based oils or bio-based fermentation products. Its technology is its gene editing platform called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits, four of which are applicable to multiple crops. These traits are PSR in Canola and HT1 and HT3 in rice. In addition, it also has two advanced traits for Sclerotinia resistance and another novel broadleaf HT trait, HT2.
CALYXTPAR 
